CA2418716A1 - Integrin binding motif containing peptides and methods of treating skeletal diseases - Google Patents

Integrin binding motif containing peptides and methods of treating skeletal diseases Download PDF

Info

Publication number
CA2418716A1
CA2418716A1 CA002418716A CA2418716A CA2418716A1 CA 2418716 A1 CA2418716 A1 CA 2418716A1 CA 002418716 A CA002418716 A CA 002418716A CA 2418716 A CA2418716 A CA 2418716A CA 2418716 A1 CA2418716 A1 CA 2418716A1
Authority
CA
Canada
Prior art keywords
bone
gly
asp
peptide
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002418716A
Other languages
English (en)
French (fr)
Inventor
Yoshinari Kumagai
Russell Wayne Blacher
Toshiyuki Yoneda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Big Bear Bio Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2418716A1 publication Critical patent/CA2418716A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4728—Calcium binding proteins, e.g. calmodulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
CA002418716A 2000-08-16 2001-08-14 Integrin binding motif containing peptides and methods of treating skeletal diseases Abandoned CA2418716A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US64103400A 2000-08-16 2000-08-16
US09/641,034 2000-08-16
US09/812,485 US6911425B2 (en) 2000-08-16 2001-03-19 Integrin binding motif containing peptides and methods of treating skeletal diseases
US09/812,485 2001-03-19
PCT/US2001/025542 WO2002014360A1 (en) 2000-08-16 2001-08-14 Integrin binding motif containing peptides and methods of treating skeletal diseases

Publications (1)

Publication Number Publication Date
CA2418716A1 true CA2418716A1 (en) 2002-02-21

Family

ID=27093672

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002418716A Abandoned CA2418716A1 (en) 2000-08-16 2001-08-14 Integrin binding motif containing peptides and methods of treating skeletal diseases

Country Status (11)

Country Link
US (5) US6911425B2 (enExample)
EP (1) EP1309616B1 (enExample)
JP (3) JP4318246B2 (enExample)
CN (1) CN100488980C (enExample)
AT (1) ATE430165T1 (enExample)
AU (2) AU8649101A (enExample)
CA (1) CA2418716A1 (enExample)
DE (1) DE60138552D1 (enExample)
ES (1) ES2324153T3 (enExample)
MX (1) MXPA03001394A (enExample)
WO (1) WO2002014360A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100359015C (zh) * 1998-05-18 2008-01-02 伦敦大学专科学院 多肽激素磷酸盐沉着因子
US6911425B2 (en) * 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases
EP1313440B1 (en) * 2000-08-16 2008-07-16 ACOLOGIX, Inc. Dental products comprising bone growth enhancing peptide
JP5160091B2 (ja) * 2003-12-01 2013-03-13 アルラ・フーズ・エイ・エム・ビィ・エイ 歯科用製剤におけるオステオポンチンの使用
US20060193916A1 (en) * 2005-01-07 2006-08-31 Acologix, Inc. Formulations of peptides for periodontal and dental treatments
WO2007011610A2 (en) * 2005-07-18 2007-01-25 Acologix, Inc. Protein formulation for promoting hard tissue formation
CN100366302C (zh) * 2006-09-14 2008-02-06 清华大学 一种用于骨修复的矿化多肽材料及其制备方法
AU2008209473B2 (en) * 2007-01-22 2012-10-25 Orthotrophix, Inc. A peptide composition and a method of promoting cartilage formation
JP5519121B2 (ja) * 2008-06-02 2014-06-11 学校法人東日本学園 新規ｒｇｄ含有ペプチドおよび象牙質再生剤、骨再生剤、歯周組織再生剤
CA2801304C (en) * 2010-06-01 2019-07-02 Belle-Aire Fragrances, Inc. Oral odor control method and product
RU2503458C1 (ru) * 2012-08-27 2014-01-10 Сергей Васильевич Чуйкин Способ местного лечения и профилактики основных стоматологических заболеваний у детей с хронической почечной недостаточностью с применением жевательного фитосубстрата
JP6692676B2 (ja) * 2016-04-12 2020-05-13 学校法人東日本学園 ネフロネクチンを含むう蝕治療剤
CN106943311A (zh) * 2017-04-07 2017-07-14 缪来耿 一种用于预防和或治疗牙周炎的牙膏及其制备方法
US10849958B2 (en) * 2017-06-14 2020-12-01 Orthotrophix, Inc. Knee pain evaluation and management via WOMAC and KOOS systems
US11963996B2 (en) 2018-10-24 2024-04-23 Orthotrophix, Inc. Method of treating knee pain
CN109762069B (zh) * 2018-11-05 2022-01-14 广州领晟医疗科技有限公司 一种融合蛋白、其药物组合物及用途
KR20210098998A (ko) 2018-12-04 2021-08-11 오르토트로픽스 인코포레이티드 골관절염 치료시 사용하기 위한 제형
CN111249446B (zh) * 2020-02-27 2023-06-27 广州领晟医疗科技有限公司 多肽及其盐的新用途
CN111358935B (zh) * 2020-02-27 2023-06-27 广州领晟医疗科技有限公司 多肽在制备抗肿瘤和/或抑制肿瘤转移药物中的用途及药物
CN111265652B (zh) * 2020-02-27 2023-06-27 广州领晟医疗科技有限公司 多肽在制备治疗缺血性脑血管疾病的药物中的应用
CN111569046B (zh) * 2020-04-14 2023-06-27 广州领晟医疗科技有限公司 多肽在制备治疗胰腺炎药物中的用途及含有其的药物
US11793857B2 (en) 2020-10-01 2023-10-24 Orthotrophix, Inc. Hard tissue therapeutics

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US5120829A (en) * 1989-03-20 1992-06-09 La Jolla Cancer Research Foundation Hydrophobic attachment site for adhesion peptides
JPH0474132A (ja) * 1990-07-13 1992-03-09 Lion Corp 歯根膜ならびに歯槽骨組織再生修復促進剤
GB9203958D0 (en) 1992-02-25 1992-04-08 Norske Stats Oljeselskap Catalytic multi-phase reactor
US5981478A (en) 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US6103709A (en) 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US6027592A (en) 1995-06-06 2000-02-22 Gillette Canada Inc. Dental floss
US6300062B1 (en) 1995-07-13 2001-10-09 Biora Ab Enamel matrix related polypeptide
US5837674A (en) 1996-07-03 1998-11-17 Big Bear Bio, Inc. Phosphopeptides and methods of treating bone diseases
EP1003570A1 (en) 1997-08-15 2000-05-31 Children's Medical Center Corporation Osteopontin coated surfaces and methods of use
US6146655A (en) 1997-08-29 2000-11-14 Softy-Flex Inc. Flexible intra-oral bandage and drug delivery system
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
WO1999043844A1 (en) * 1998-02-27 1999-09-02 The Trustees Of Columbia University In The City Of New York Reciprocal subtraction differential display
CN100359015C (zh) 1998-05-18 2008-01-02 伦敦大学专科学院 多肽激素磷酸盐沉着因子
US6673900B2 (en) * 1999-11-04 2004-01-06 University College London Polypeptide hormone-phosphatonin
US6045780A (en) 1998-06-22 2000-04-04 Shemberg Marketing Corporation Toothpaste composition
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US6145655A (en) * 1999-10-04 2000-11-14 Tsai; Allan Lens cleaning kit
EP1130098A3 (en) 2000-02-29 2003-09-10 Pfizer Products Inc. Mammalian osteoregulins
WO2001072826A2 (en) 2000-03-24 2001-10-04 Genzyme Corporation Oncogenic osteomalacia-related gene 1
CN100350971C (zh) 2000-07-19 2007-11-28 奥索洛吉艾斯有限公司 用凝血酶肽衍生物刺激骨生长
EP1313440B1 (en) * 2000-08-16 2008-07-16 ACOLOGIX, Inc. Dental products comprising bone growth enhancing peptide
US6911425B2 (en) 2000-08-16 2005-06-28 Acologix, Inc. Integrin binding motif containing peptides and methods of treating skeletal diseases

Also Published As

Publication number Publication date
DE60138552D1 (de) 2009-06-10
US20070014742A1 (en) 2007-01-18
EP1309616A1 (en) 2003-05-14
US6911425B2 (en) 2005-06-28
ES2324153T3 (es) 2009-07-31
US7160862B2 (en) 2007-01-09
JP2007302673A (ja) 2007-11-22
MXPA03001394A (es) 2004-12-13
WO2002014360A1 (en) 2002-02-21
JP2004506654A (ja) 2004-03-04
CN1458935A (zh) 2003-11-26
JP4318246B2 (ja) 2009-08-19
AU8649101A (en) 2002-02-25
JP2011032286A (ja) 2011-02-17
EP1309616B1 (en) 2009-04-29
US20090042791A1 (en) 2009-02-12
US20020197267A1 (en) 2002-12-26
AU2001286491B2 (en) 2006-04-27
US20050163728A1 (en) 2005-07-28
CN100488980C (zh) 2009-05-20
ATE430165T1 (de) 2009-05-15
US20090062201A1 (en) 2009-03-05
EP1309616A4 (en) 2004-12-08

Similar Documents

Publication Publication Date Title
US20090042791A1 (en) Integrin binding motif containing peptides and methods of treating skeletal diseases
AU2001286491A1 (en) Integrin binding motif containing peptides and methods of treating skeletal diseases
US20090163413A1 (en) Dental products comprising bone growth enhancing peptide
CN112105340B (zh) 用于缓解牙本质感觉过敏的牙膏组合物
AU2001283268A1 (en) Dental products comprising bone growth enhancing peptide
JP2004501976A (ja) ペプチド組成物
JP2017526653A (ja) 骨分化促進能及び歯周靭帯線維母細胞活性促進能を有するペプチド及びその用途
CN116082483B (zh) 一种具有改善骨质疏松、增强骨密度的多肽制备方法及应用
RU2811919C1 (ru) Фармацевтическая композиция для предотвращения или лечения пародонтоза или травматического вывиха зуба
JPH07258110A (ja) 骨疾患治療剤
HK40085189A (en) Pharmaceutical composition for preventing or treating a periodontal disease or dislocated traumatic tooth
HK40040392A (en) Toothpaste composition for alleviating dentin hypersensitivity

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued